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Purpose: To evaluate the feasibility of performing fetal
brain magnetic resonance venography using susceptibility
weighted imaging (SWI).
Materials and Methods: After obtaining informed con-
sent, pregnant women in the second and third trimester
were imaged using a modified SWI sequence. Fetal SWI
acquisition was repeated when fetal or maternal motion
was encountered. The median and maximum number of
times an SWI sequence was repeated was four and six
respectively. All SWI image data were systematically eval-
uated by a pediatric neuroradiologist for image quality
using an ordinal scoring scheme: 1. diagnostic; 2. diag-
nostic with artifacts; and 3. nondiagnostic. The best score
in an individual fetus was used for further statistical
analysis. Visibility of venous vasculature was also scored
using a dichotomous variable. A subset of SWI data was
re-evaluated by the first and independently by a second
pediatric neuroradiologist. Kappa coefficients were com-
puted to assess intra-rater and inter-rater reliability.
Results: SWI image data from a total of 22 fetuses were
analyzed. Median gestational age and interquartile range
of the fetuses imaged were 32 (29.9–34.9) weeks. In
68.2% of the cases (n¼15), there was no artifact; 22.7%
(n¼5) had minor artifacts and 9.1% (n¼2) of the data
was of nondiagnostic quality. Cerebral venous vascula-
ture was visible in 86.4% (n¼19) of the cases. Substan-
tial agreement (Kappa¼0.73; 95% confidence interval
0.44–1.00)) was observed for intra-rater reliability and
moderate agreement (Kappa¼0.48; 95% confidence inter-
val 0.19–0.77) was observed for inter-rater reliability.
Conclusion: It is feasible to perform fetal brain venogra-
phy in humans using SWI.
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FETUSES WHO SUFFER stroke in utero are at
increased risk of neurodevelopmental disorders (1,2),
particularly hemiplegic cerebral palsy (3,4). Fetal
stroke is broadly defined as an ischemic, thrombotic
or hemorrhagic event occurring between 14 weeks of
gestation and the onset of labor resulting in delivery
(5). While most of the magnetic resonance (MR) imag-
ing methods used in adult stroke imaging could be
applied to postnatal imaging of the neonates, method-
ologies for evaluating and studying fetal stroke in
utero are limited due to constraining factors specific
to fetal imaging (6). Blood oxygen level dependent
(BOLD) based signal changes in MR susceptibility
weighted imaging (SWI) have been used previously in
evaluating and studying stroke not only in adults, but
also in pediatric (7,8) and neonatal populations (9–
11). SWI has also been used in studying traumatic
brain injury in the pediatric population due to its sen-
sitivity to hemorrhagic lesions (12–15). SWI is a high
resolution, fully flow compensated MR imaging tech-
nique, which is more sensitive than the typical T2*
based BOLD acquisition because of its unique combi-
nation of the T2* weighted magnitude data with the
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phase data (16,17). Phase image from gradient echo
sequences like SWI provides distinctive contrast, dif-
ferent from the conventional T1, T2, and T2* contrast,
accentuating small differences in tissue magnetic sus-
ceptibility property. Because of this, SWI is used in dis-
tinguishing arteries from veins (18–20), is sensitive to
microbleeds (16,21) and to changes in venous oxygen
saturation (22–25) and has also been used to quantify
cerebral venous oxygen saturation (26). In a stroke,
increased oxygen extraction in the tissue with reduced
perfusion leads to an increase in deoxyhemoglobin
content in the veins and could lead to their prominent
appearance on SWI (25,27). Unusually prominent deep
medullary veins have been identified on SWI in hypoxic
ischemic injury (HII) in neonates (10). Kitamura et al
reported neonates with HII with a normal appearance
of deep medullary veins on SWI are more likely to have
normal neurologic outcomes compared to patients with
prominent deep medullary veins (10).
Given the sensitivity of SWI as a venographic tech-
nique, its utility in evaluating stroke in adult, pediatric
and neonatal populations and its potential for quanti-
tative evaluation of blood oxygenation, we anticipate
that SWI may be an important tool in fetal brain imag-
ing as well, especially for studying and imaging
hypoxic ischemic injury. Hence, the purpose of this
work was to evaluate the feasibility of performing
venography of the fetal brain using SWI. Specifically,
we adapted clinically available SWI sequence for fetal
brain imaging, applied it to imaging normal fetuses
and evaluated the quality of the acquired images.
MATERIALS AND METHODS
Study Population
Twenty-two pregnant women with singleton pregnancies
between 18 to 38 years and 19 and 40 weeks of gesta-
tion, who were receiving care at the Hutzel Women’s
Hospital in Detroit, MI, USA were non-consecutively
recruited. Women with uncomplicated pregnancies, a
normal ultrasound examination and reporting no con-
traindications for MRI were eligible to participate. The
study was approved by the local institutional review
board and was compliant with HIPAA. Written informed
consent was obtained before the MRI scan. No sedation
was used for fetal MRI scan. Study participants were fol-
lowed longitudinally to assure that they did not develop
complications during pregnancy. The median gesta-
tional age of the fetuses included was 32 weeks with the
interquartile range of 29.9 to 34.9 weeks.
MR Imaging Protocol
Three of the women were scanned on a 1.5 Tesla (T)
GE Signa system (Milwaukee, WI) and the remaining
(n¼19) on a 3.0T Siemens Verio system (Erlangen,
Germany).
Imaging at 1.5T
An eight-channel cardiac array with spine receive coils
were used for imaging. Normal anatomical data were
acquired using a T2 weighted single shot fast spin echo
(SSFSE) technique with repeat time (TR) between 1192
and 1240 milliseconds (ms), echo time (TE) 242 ms,
slice thickness of 4 mm, voxel size 1.13  1.13 mm2,
flip angle of 90 and acquisition matrix size of 256 
160. Fetal SWI sequence was implemented by modify-
ing the imaging parameters of a two-dimensional (2D)
multiecho, fast spoiled gradient echo sequence with
flow compensation. The sequence was modified to save
both magnitude and phase data. The following
sequence parameters were used: TR¼80 to 105 ms,
TEs¼8.4, 16.8, 25.3, 33.7 ms, slice thickness of 5 or 6
mm, flip angle 18, field of view (FOV) 350  350 mm2,
acquisition matrix size of 512  256, giving an acquisi-
tion voxel size of 0.7  1.4  5 mm3. A parallel imaging
factor of 2 in phase encoding direction was used.
Images were interpolated to a matrix size of 512  512,
with an apparent voxel size of 0.7  0.7 mm2 in-plane.
The sequence was implemented in a multi breath-hold
mode and the total data acquisition time depended on
the number of slices acquired. Imaging time for acquir-
ing two slices was typically between 24 and 26 s. Vol-
ume coverage was achieved by acquiring multiple slices
in a multi breath-hold mode with a total acquisition
time for 12 slices of approximately 2.5 min.
Imaging at 3.0T
A six-channel body flex array coil with the spine
receive coil were used for imaging. Anatomical data
were acquired using a T2-weighted single shot turbo
spin echo sequence with half-Fourier reconstruction
(HASTE sequence) using the following parameters: TR
3000 ms, TE 140 ms, slice thickness 3 mm, voxel size
of 0.87  0.87 mm2 in-plane, flip angle 75 and an
acquisition matrix of 320  320. Imaging parameters
of the conventional SWI sequence were modified for
the fetal imaging application for fast data acquisition.
Both two and three dimensional (2D and 3D) data
acquisition versions the SWI sequence were
implemented for fetal brain imaging as described
below. For 2D fetal SWI, a 2D spoiled gradient echo
imaging sequence with flow compensation in all three
directions and TR of 250 to 280 ms, TE between 17 to
19 ms, slice thickness of 3 or 3.5 mm, voxel size of
0.78  1.56 mm2 in-plane, flip angle 32, a parallel
imaging factor of 2 along phase encoding direction,
and an acquisition matrix size of 448  168 was
implemented. Images were interpolated to 0.78  0.78
mm2 in-plane resolution. A total of 10 or 11 slices
were collected within an acquisition time of 22 to 24
s. For 3D fetal SWI, a 3D spoiled gradient echo
sequence with flow compensation in all three direc-
tions and TR between 20 and 23 ms, TE between 13
and 17.3 ms, slice thickness of 3 or 3.5 mm, voxel
size 0.78  1.56 mm2 in-plane, flip angle 10, and an
acquisition matrix size of 448  175 was imple-
mented. Reconstructed images were interpolated by
zero filling to 0.78  0.78 mm2 in-plane resolution. A
total of 16 slices were acquired and total data acquisi-
tion time was approximately 22 to 24 s. Both 2D and
3D SWI sequence at 3.0T were applied under mater-
nal breath-hold condition.
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Except for the cases where fetal motion precluded
it, SWI data was acquired in axial orientation relative
to the fetal brain. The 2D SWI sequence was applied
in all but one fetal MR scan (n¼21); whereas, 3D-SWI
data were collected only in a few fetal scans when
total scan time restrictions permitted (n¼15). Magni-
tude and phase images obtained from these SWI
sequences were processed as described in Haacke et
al (19) to obtain the SWI image data. Table 1 summa-
rizes the key imaging parameters of the fetal SWI
sequences. In most fetal scans, SWI data acquisition
(2D and/or 3D) was repeated when motion was
encountered. This repeated image acquisition is com-
mon place in clinical fetal imaging (28). The median
number of times an SWI acquisition (2D and/or 3D)
was repeated in a fetus was four with a maximum of
six, which was in only one fetus.
Data Evaluation
All SWI image data (henceforth referred to as SWI
data) from the fetal scans were evaluated for image
quality using an ordinal quality scoring scheme by a
pediatric neuroradiologist (S.M.) with 12 years of
experience. Specifically, image quality assessment
was focused on the fetal brain region only as that is
the region of investigation in this study. The ordinal
scoring criteria for image quality is given in Table 2.
Images of diagnostic quality with good magnitude def-
inition and no artifacts were given the score of 1.
Image volumes with minor artifacts but still of diag-
nostic quality were scored as 2. Images of nondiag-
nostic quality with poor magnitude definition and
major artifacts were scored as 3. Both 2D and 3D SWI
data were scored individually for image quality.
Because multiple 2D and/or 3D SWI data were often
acquired in one fetal scan, an overall SWI data quality
score was then determined for that particular fetus by
taking the minimum of the scores of all SWI scans for
that fetus. Furthermore, the SWI dataset receiving the
optimal score was then evaluated for visibility of cere-
bral venous vasculature using a dichotomous, Yes (1)
>No (0) classification by the same pediatric neuroradi-
ologist (S.M.). A value of 1 was assigned when veins in
deep white matter or cortical veins were visible; other-
wise 0 was assigned. Because the SWI scan volume
covered slightly different regions of the brain for dif-
ferent fetuses, due to limited volume coverage and dif-
ferent fetal brain sizes, evaluation of visibility of a
single common venous structure across all fetuses
was not feasible.
Of the 22 fetuses scanned, 19 were randomly chosen
for evaluating intra-rater and inter-rater agreements.
The quality of the SWI data acquired from this subset
of fetuses was reviewed and scored using the same
ordinal scale as described above, in a blinded manner
by another neuroradiologist for inter-rater agreement
evaluation. The scoring of this subset of fetal SWI data
was repeated by the first neuroradiologist (S.M.) with a
gap of 6 months between the first and the second
reviews for intra-rater agreement evaluation. For each
reviewer, the overall SWI data quality score, obtained
by taking the minimum of the scores of all SWI scans
for an individual fetus, was used for further statistical
analysis. This process of considering the best image
volume of the available scan data is similar to the
image review process in clinical fetal imaging, where
sequences are repeated until images without fetal
motion are obtained and the best quality scan data is
used for diagnostic purposes. Cichetti-Allison weighted
kappa coefficients were calculated as a measure of
inter- and intra- rater agreement. A priori classifica-
tions of Kappa coefficients were as follows: “0” as indi-
cating no agreement; “0–0.20” as slight agreement;
“0.21–0.40” as fair agreement, “0.41–0.60” as moder-
ate agreement; “0.61–0.80” as substantial agreement;
and “0.81–1.0” as near perfect agreement. A 5%
threshold for type I error was used to determine statis-
tical significance. Statistical analyses were performed
using SAS version 9.3 (Cary, NC).
RESULTS
Representative examples of the SWI data are shown in
Figure 1. The phase signature of the veins, due to
Table 1
MR Imaging Parameters for Fetal SWI
Sequence
mode TR(ms) TE(ms)
In plane reconstructed
voxel size (mm) Slice thickness (mm) BW (Hz/pixel) No. of slices
1.5T (GE Signa)
2D 100 or 105 33.7 0.7 x 0.7 5 to 6 mm 122 12
3T (Siemens Verio)
2D 250 to 280 17 to 19 0.78 x 0.78 3 to 3.5 mm 199 11
3D 20 to 23 13.5 to 17.3 0.78 x 0.78 3 to 3.5 mm 219 16
Table 2
Ordinal Scoring Scheme for Image Quality Assessment
Quality scoring index
Score Interpretation
No. of datasets
receiving the
score
1 Diagnostic quality images with good
magnitude definition and no artifacts.
n¼15
2 Minor artifacts being present but overall
image volume is still of diagnostic
quality.
n¼5
3 Non-diagnostic images with very poor
magnitude definition and containing
major artifacts.
n¼2
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their paramagnetic nature, is clearly visible in the
images (Figs. 1b,e) and helps in enhancing magnitude
contrast after SWI processing (Figs. 1c,f) (29,30). Of
SWI data reviewed from 22 fetuses, 68.2% (n¼15)
was found to be of diagnostic quality with no artifacts
and received the optimal score of 1. Minor artifacts
were seen in 22.7% (n¼5) of the cases which were
still of diagnostic quality and received a score of 2. In
9.1% (n¼2) of the cases, images were of nondiagnos-
tic quality and received a score of 3 due to severe arti-
facts resulting either from fetal motion, small imaging
FOV or bulk susceptibility artifacts from air–tissue or
bone–tissue interface. These results are summarized
in Table 2. SWI data, which received a score of 2, typi-
cally had coil drop-off (ie, varying signal to noise ratio
(SNR), from high to low across the image),
artifacts from a small FOV or susceptibility related
artifacts. Examples of the typical artifacts seen in the
Figure 1. Susceptibility weighted images of the fetal brain. Top Row: Images were acquired in axial orientation relative to the
fetus using a 3D SWI sequence at 3.0T field strength from a fetus at 36 3/7 weeks of gestation. Bottom Row: Images were
acquired in coronal orientation relative to the fetus using a 2D SWI sequence at 1.5T field strength from a fetus at 35 3/7
weeks of gestation. a,d: Original magnitude images. b,e: Corresponding filtered phase images. c,f: Corresponding susceptibil-
ity weighted magnitude image (SWI image). Veins are already seen to some extent in the original magnitude images (a,d) due
to T2* signal loss; white arrow head in (a) indicating the thalamostriate vein. Phase images in (b,e) also show the veins with
their characteristic phase signature. After applying the mask generated using this phase information to the corresponding
original magnitude images, processed SWI images in (c,f) clearly improve the vessel contrast (white arrow in (a) and black
arrow head in (f)). Imaging resolution corresponding to the scan in the top row (3.0T - 2D SWI) was 0.78  1.5  3 mm3
(reconstructed to 0.78  0.78 mm2 in-plane) and 0.7  0.1.4  5 mm3 (reconstructed to 0.7  0.7 mm2 in-plane) for the bot-
tom row (1.5T - 2D SWI).
Figure 2. Unprocessed SWI magnitude images illustrating typical image quality and artifacts seen and their respective
scores. a: Image containing fetal motion artifact and an artifact due to small FOV; score 3. b: Image with varying signal to
noise ratio across the fetal brain region. This is due to insufficient reference lines required for image reconstruction with par-
allel imaging; score 2. c: Another image with score 2, containing what appears as a ripple artifact in one part of the fetal
brain. This artifact is due to signal contamination from tissue outside the small field of view; score 2. d: Fetal image with visi-
bly no artifacts in the fetal brain region; score 1.
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images with their corresponding scores are shown in
Figure 2.
SWI data from 19 fetuses were assessed twice by a
single rater to estimate intra-rater reliability and once
more by an additional rater to assess inter-rater reli-
ability. Overall, substantial intra-rater agreement was
observed (Kappa¼0.73; 95% confidence interval
0.44–1.00). As shown in Table 3, discrepancies within
repeated assessments by rater-1 included three data-
sets that were first graded as diagnostic quality with
some artifacts and were later considered to be of diag-
nostic quality without any artifacts. As shown in
Table 4, moderate agreement (Kappa¼0.48; 95% con-
fidence interval 0.19–0.77) was observed for inter-
rater reliability. Eight images classified as diagnostic
quality without any artifacts by rater-1 were classified
by rater-2 as having some artifacts (n¼7) or being of
nondiagnostic quality (n¼1). Additionally, one image
classified by rater-2 as nondiagnostic quality (score-
¼3) received a diagnostic quality with artifacts rating
(score¼2) by rater-1. However, when only a binary
classification of diagnostic quality versus nondiagnos-
tic quality was considered, agreement was greater
than that observed for the three category classifica-
tions: 100% intra-rater agreement (agreed on 19/19),
and 90% inter-rater agreement (agreed on 17/19).
Cerebral venous vasculature was visible in 86.4%
(n¼19) of the cases, and in 100% of those imaged
after 32 weeks of gestation (n¼10). Figure 3 illus-
trates the proportion of cases in which venous vascu-
lature was visible by gestational age interval.
Minimum intensity projection SWI images from differ-
ent fetuses at different gestational ages are shown in
Figure 4. This collage illustrates the different extent of
venous vasculature visualized on SWI as the gesta-
tional age progresses. Finally, Figure 5 demonstrates
in detail the venous vasculature in a fetus at 37 1/7
weeks of gestation. By comparing venous structures
visualized in this fetus with what is typically seen in
adult SWI venography, major veins like thalamostriate
veins, internal cerebral veins, anterior septal veins,
and basal vein of Rosenthal are clearly identified.
DISCUSSION
In this study, fetal brain MR venography was per-
formed using SWI and image quality was evaluated.
While venous vasculature was visible on SWI in
86.4% of the fetuses, only moderate inter-rater agree-
ment was seen in SWI image quality. It is important
to note here that, while all the SWI data acquired in
an individual fetus were evaluated for data quality,
only the best score obtained in an individual fetus
was used for inter- and intra-rater agreement analy-
sis. The reported data quality results are also from
the best score in a given fetus. Using the best data
quality rating in an individual fetus is representative
of the conventional clinical fetal imaging process
where acquisition for different sequences are often
repeated whenever motion is encountered and the
acquisition with the best data quality is then used by
the radiologist for diagnostic purposes. Both SWI
Table 3
Intra-rater Reliability*
Rater-1 - Time 2
Rater-1 – Time 1
1 - Diagnostic quality
images without any
artifacts
2 - Diagnostic quality
images with
some artifacts
3- Nondiagnostic
quality images Total
1 - Diagnostic quality images without
any artifacts
10 0 0 10
2 - Diagnostic quality images with
some artifacts
3 5 0 8
3- Nondiagnostic quality images 0 0 1 1
Total 13 5 1 19
*In a subset of cases fetal brain SWI data quality was assessed a pediatric neuroradiologist twice with a 6-month gap between the first
and second assessment.
Table 4
Inter-rater Reliability
Rater-2
Rater-1
1 - Diagnostic quality
images without any
artifacts
2 - Diagnostic quality
images with some artifacts
3- Nondiagnostic
quality images Total
1 - Diagnostic quality images without
any artifacts
5 7 1 13
2 - Diagnostic quality images with
some artifacts
0 4 1 5
3- Nondiagnostic quality images 0 0 1 1
total 5 11 3 19
*In a subset of cases, fetal brain SWI data quality was assessed by a second pediatric neuroradiologist for evaluating inter-rater reliability.
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image quality and visibility of veins depend on many
sequence parameters such as the TE, TR, flip angle,
voxel size, and the number of averages. In the case of
fetal imaging, an additional constraint of total imaging
time is imposed. Rapid data acquisition is required for
fetal imaging, mainly to minimize the effects of any
maternal respiratory motion and to reduce the proba-
bility of fetal motion occurring during the scan. In
this study, conventional clinical 2D and 3D SWI
sequence parameters were modified to bring the total
data acquisition time to between 21 and 25 s which is
a typical maternal breath-hold capacity in pregnancy
(31). Data acquisition matrix size (consequently the
voxel size), TR, and TE were the primary experimental
parameters that needed to be adjusted for the total
acquisition time to be within 25 s. Flip angle was
adjusted according to the changes in TR to maintain
good SNR. Notably, to achieve this reduction in scan
time, larger voxel sizes had to be used compared to
conventional 0.5  1  2 mm3 voxel size that is typi-
cally used in a clinical adult brain SWI (32). This
could adversely affect visualization of smaller veins in
SWI due to partial volume effects (33). Because of the
small number of fetuses in which both 2D and 3D
SWI data was acquired and the number of repeat
acquisitions for each differed from case to case, a sta-
tistical evaluation comparing the data quality of 2D
and 3D SWI was not completed. However, a cursory
comparison of the data quality scores of 2D and 3D
SWI acquisitions (minimum possible score for 2D and
3D acquisitions) shows that in 12 of these 14 fetuses
(85.7%), data quality of 2D SWI was equal to or
better than that of 3D SWI. This is in broad agree-
ment with what is theoretically expected based on the
differences in 2D and 3D MRI data acquisition
schemes. Due to the long duration over which parti-
tion (slice direction) encoding for the whole imaging
volume occurs in 3D sequences, they are typically
more susceptible to motion artifacts than 2D acquisi-
tion methods (34).
Figure 3. Proportion of cases with visible cerebral venous
vasculature by gestational age at image assessment.
Figure 4. Fetal brain venograms generated from SWI images (minimum intensity projections). Venograms from different
fetuses at different gestational ages are shown to illustrate the variation of visualized cerebral venous vasculature in the
human fetus with gestational age.
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Visibility of veins in SWI is dependent on the phase
signature of the venous vasculature, which in-turn is
a function of blood oxygenation level, blood hemato-
crit and the magnetic susceptibility of fetal blood
(35,36). Fetal blood hematocrit changes with gesta-
tional age, increasing almost linearly from approxi-
mately 33% at 20 weeks to 43% at term (37).
Oxygenation of the arterial blood supply of the fetus,
by means of the umbilical vein, is also known to
change with gestational age (38), which may result in
a related variation in venous oxygen saturation with
gestational age. Furthermore, fetal hemoglobin has a
slightly different morphology that leads to its
increased oxygen binding affinity compared with adult
hemoglobin. Because the MR visible magnetic prop-
erty of blood, namely its magnetic susceptibility, is
modulated by oxygenation or de-oxygenation of hemo-
globin, this difference in conformation of fetal hemo-
globin with respect to adult hemoglobin, may
translate to different magnetic properties (39–41) of
fetal blood compared to adult blood. Cerebral blood
flow rate also influences oxygen extraction fraction
(35). All these factors, namely hematocrit, magnetic
susceptibility of fetal blood, and blood flow can affect
the net phase seen in veins. At least one of these fac-
tors, namely hematocrit if not all, is known to change
with fetal gestational age. Thus, normal physiological
variation in the developing venous vasculature along
with gestational age may be affecting venous phase
and their visibility in SWI. The variation in the extent
of visible venous vasculature with gestational age
illustrated in the images shown in Figure 4 supports
this hypothesis. Additionally, as mentioned above,
SWI sequence parameters such as TE and image reso-
lution can influence visibility of veins (42,43). Specifi-
cally, the longer the TE the better the phase definition
within the veins, and the smaller the voxel size, the
better the visibility of smaller veins. Although there is
some variation in the TEs used in acquisition of data,
because this variation was only between 2 and 4 ms,
we do not expect its influence to be significant on the
variability in venous visibility in this study.
SWI requires additional postprocessing for combin-
ing magnitude and phase information. Apart from the
factors mentioned above, fetal head orientation rela-
tive to the main magnetic field also influences venous
phase in SWI. Hence, conventional SWI post-process-
ing performed on MR magnet consoles is not appro-
priate for fetal SWI. This problem was overcome in
this study by appropriately modulating the phase
mask generation step (29,44) to account for arbitrary
head orientation. Specifically, linear phase mask with
appropriate sign for enhancing venous vasculature
was chosen depending on the sign of the venous
phase. Recently developed post-processing methods
(45), which are independent of fetal head orientation
could also alleviate this problem. However, higher
resolution data would be required for the optimal
Figure 5. Venous vasculature in a 37 1/7 week fetus, identifiable based on adult venous anatomy. a: Septal vein (red), Thala-
mostriate vein (blue), Internal cerebral veins (yellow). b: medial atrial vein (green), superior sagittal sinus (orange). c: Basal
vein of Rosenthal (light blue), deep middle cerebral vein (pink). Images shown here are minimum intensity projection SWI
images, projected over 12 mm thickness of tissue to show contiguity of venous vasculature within. These fetal data were
acquired at 3T field strength using a 3D SWI sequence. SWI images from an adult brain are shown in (d) for visual compari-
son of the venous anatomy.
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application of this methodology. Artifacts related to
the small FOV, fetal motion and susceptibility effects
from air–tissue or bone–tissue interface affected the
SWI image quality in this study. Artifacts related to
the small FOV refer to aliasing artifacts arising from
signal contributions from outside the FOV which were
seen to disappear when a larger FOV was used for
imaging. These artifacts can be avoided using outer-
volume suppression (or reduced FOV) techniques,
which allow precise excitation of a small region of
interest within a larger object (46,47). These reduced
FOV imaging techniques could also be used to achieve
higher spatial resolution. In conjunction with reduced
FOV imaging, novel sampling and reconstruction
schemes like segmented echo planar imaging could
provide a factor 3 to 5 decrease in data acquisition
time (48). For a fixed imaging time, such schemes
could further be used for obtaining higher resolution
data which can further improve image quality and vis-
ualization of veins in SWI.
There are a few limitations to this study. Although
fetal SWI data from 1.5T and 3T was evaluated, due
to the small number of fetal scans at 1.5T, compari-
son could not be made between image quality and
venous visibility at 1.5T versus 3.0T. Similarly,
because 3D SWI was not acquired in all cases, a
comparision of data quality and visibility of veins
between 3D versus 2D fetal SWI were not carried
out. A key aspect in this study is that without any
pulse sequence modification, conventional, clinically
available sequences were modified to obtain fetal SWI
data. Despite this, data from only 31.8 % (n¼7) of
the cases contained artifacts. This shows that fetal
SWI data could be obtained clinically with currently
available SWI sequences. However, with appropriate
pulse sequence modifications using novel fast imag-
ing techniques (46,48) the speed of data acquisition
and imaging resolution can significantly be
improved. Finally, the clinical value of SWI was not
assessed. Future studies with SWI scan data from a
larger number of normal and at-risk fetuses would
be required to ascertain the clinical utility of fetal
SWI. Nonetheless, a recent case report already high-
lights the clinical utility of SWI in imaging the fetal
brain in cases of suspected intra-cerebral hemor-
rhage (49).
In conclusion, we have demonstrated the feasibility
of performing magnetic resonance venography of the
fetal brain in humans using clinically available con-
ventional susceptibility weighted imaging sequence.
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